209 CONFIRMING PHASE III CLINICAL TRIAL TO STUDY THE EFFICACY OF A P.A.F. ANTAGONIST, BN 52021 [BN], IN REDUCING MORTALITY OF PTS WITH SEVERE GRAM-NEGATIVE SEPSIS [GNS]
- 1 May 1995
- journal article
- abstracts
- Published by Wolters Kluwer Health in Shock
- Vol. 3 (5) , 65
- https://doi.org/10.1097/00024382-199505000-00209
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: